Search - tctmd.com

Displaying 901 - 920 of 1412

Sort: Relevancy | Date

Presentation TVT 2022

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Presenter: Geraldine Ong, Gilbert H. L. Tang, Yan Topilsky

June 10, 2022

Presentation TVT 2022

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

Presenter: Alexandra Lansky

June 10, 2022

Presentation TVT 2022

TV Replacement Will Win: Ease of Use and TR Reduction Are Key!

Presenter: Rebecca T. Hahn

June 10, 2022

Presentation TVT 2022

Novel Embolic Protection Technologies: The Current State of Play

Presenter: Giora Weisz

June 10, 2022

Presentation TVT 2022

TV Repair Will Dominate: Safety Will Always Prevail!

Presenter: Paul Sorajja

June 10, 2022

Presentation TVT 2022

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Presenter: Samir Kapadia

June 10, 2022

Presentation TVT 2022

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

Post-procedural Management of Conduction Disturbances, Including MCOT

Presenter: Amar Krishnaswamy

June 10, 2022

Presentation TVT 2022

Facilitated Tricuspid-TEER With Reverse Trendelenburg: Technique and Outcomes

Presenter: Rebecca T. Hahn

June 10, 2022

Presentation TVT 2022

Preventing Permanent Pacemakers: Procedural Optimization to Minimize Conduction Disturbances

Presenter: Amit Vora

June 10, 2022

Presentation TVT 2022

3D ICE-Guided Tricuspid-TEER: Devices Available and Technique

Presenter: Mackram F. Eleid

June 10, 2022

Presentation TVT 2022

TAVR Case-based Decisions: When to Pace, Observe, or EP Study

Presenter: Chetan Huded

June 10, 2022

Presentation TVT 2022

Lessons Learned From Early Generation Transcatheter Annular Reduction Technologies

Presenter: Susheel K. Kodali

June 10, 2022

Presentation TVT 2022

Predictors and Prognostic Implications of LBBB and CHB After TAVR

Presenter: Tamim Nazif

June 10, 2022

Presentation TVT 2022

Tricuspid Annular Reduction: Stand-Alone or Adjunctive Therapy?

Presenter: Steven F. Bolling

June 10, 2022

Presentation TVT 2022

Update For 2022: Changing Incidence of Conduction Disturbances After TAVR

Presenter: Amit Vora

June 10, 2022

Presentation TVT 2022

What's best for my patient when it comes to their post-implant drug regimen?

Presenter: Megan Coylewright

June 10, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

A CLINICAL TEASER: Indications and Clinical Outcomes of TEER in Acute Decompensated Heart Failure

Presenter: Gilbert Tang

June 10, 2022

Advertisement

Quality-of-life Assessments and Cost-effectiveness Analyses in TTVI Trials

Clinical Trial Pathways and Study Designs: Embolic Capture vs Deflection Devices

TV Replacement Will Win: Ease of Use and TR Reduction Are Key!

Novel Embolic Protection Technologies: The Current State of Play

TV Repair Will Dominate: Safety Will Always Prevail!

Stroke Prevention With Sentinel: Update From PROTECTED TAVR and BHF PROTECT-TAVI

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Post-procedural Management of Conduction Disturbances, Including MCOT

Facilitated Tricuspid-TEER With Reverse Trendelenburg: Technique and Outcomes

Preventing Permanent Pacemakers: Procedural Optimization to Minimize Conduction Disturbances

3D ICE-Guided Tricuspid-TEER: Devices Available and Technique

TAVR Case-based Decisions: When to Pace, Observe, or EP Study

Lessons Learned From Early Generation Transcatheter Annular Reduction Technologies

Predictors and Prognostic Implications of LBBB and CHB After TAVR

Tricuspid Annular Reduction: Stand-Alone or Adjunctive Therapy?

Update For 2022: Changing Incidence of Conduction Disturbances After TAVR

What's best for my patient when it comes to their post-implant drug regimen?

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

More Support for Single Antiplatelet Therapy After TAVI

A CLINICAL TEASER: Indications and Clinical Outcomes of TEER in Acute Decompensated Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content